Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Conditions

Seminoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Hodgkin Disease 2Vulvar Neoplasms 1Testicular Neoplasms 1Teratoma 1Skin Neoplasms 1Ovarian Germ Cell Cancer 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Gynecological Cancers 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Etoposide 4Cisplatin 4lutetium Lu 177 dotatate 2fludarabine phosphate 2fludarabine 2Cyclophosphamide 2Bleomycin 2repotrectinib 1pegfilgrastim 1etoposide phosphate 1copper dotatate CU-64 1Watchful Waiting 1Vorinostat 1Teniposide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Injections 1Immunotherapy 1Filgrastim 1Drug Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Germ Cell and Embryonal × Bleomycin × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting
500 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡